Peter Kubitz, DO
Physical Medicine & Rehabilitation · Phoenix, AZNPI 1750373718
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,815 of the $6,908 with a category attached, or 84.2%. It is spread thinly across 32 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,846 and has fallen 79.3% since, to $588 in 2025. Among physical medicine & rehabilitation clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 287 payments — averaging $24.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertiflex, Inc.$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$893
- Nevro Corp.$777
- Collegium Pharmaceutical, Inc.$548
- AbbVie$530
- Nalu Medical, Inc.$465
- plus $2K from 26 others
What the payments were for
- Travel & lodging$1,09316%
- Food & beverage$5,81584%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertiflex, Inc. | 13 | $1,493 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 77 | $893 |
| Nevro Corp. | 30 | $777 |
| Collegium Pharmaceutical, Inc. | 55 | $548 |
| AbbVie | 22 | $530 |
| Nalu Medical, Inc. | 16 | $465 |
| Medtronic(2 entities) | 5 | $451 |
| Boston Scientific | 16 | $366 |
| Abbott | 6 | $182 |
| Stimwave Technologies Incorporated | 1 | $180 |
| Lundbeck LLC | 2 | $171 |
| Saluda Medical Americas, Inc. | 7 | $152 |
| Teva Pharmaceuticals USA, Inc. | 5 | $75 |
| MDD US Operations, LLC | 5 | $72 |
| Scilex Pharmaceuticals Inc. | 3 | $64 |
| Relievant Medsystems, Inc. | 1 | $59 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $58 |
| SPR Therapeutics, Inc | 1 | $37 |
| Biotronik NRO, Inc. | 2 | $37 |
| Vertos Medical, Inc. | 2 | $36 |
| Fidia Pharma USA Inc. | 2 | $33 |
| Johnson & Johnson | 2 | $32 |
| West Therapeutics Development, LLC | 1 | $27 |
| Biodelivery Sciences International, Inc. | 2 | $26 |
| Pfizer | 2 | $26 |
| Ferring Pharmaceuticals Inc. | 1 | $23 |
| Vertex | 1 | $18 |
| Redhill Biopharma Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Zyla Life Sciences, Inc. | 1 | $16 |
| Virtus Pharmaceuticals LLC | 1 | $14 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion ISS$1,222
- Senza Spinal Cord Stimulation System$291
- INTELLIS ADAPTIVESTIM$284
- VYEPTI$149
- Nalu Neurostimulation System$138
- UNID_PASS$136
- SUPERION$116
How this compares
$6,908 in reported general payments places this provider in the 90th percentile of 162 physical medicine & rehabilitation providers in Arizona.
See all physical medicine & rehabilitation providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 54 | $14,400 |
| Xtampza ErOxycodone Myristate | 21 | $13,974 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 204 | $4,877 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 148 | $4,201 |
| Pregabalin | 127 | $3,108 |
| Oxycodone Hcl | 154 | $2,335 |
| Fentanyl | 25 | $1,252 |
| Gabapentin | 80 | $1,216 |
| Tramadol Hcl | 109 | $1,118 |
| Duloxetine Hcl | 100 | $806 |
| Morphine Sulfate ErMorphine Sulfate | 41 | $802 |
| Tizanidine Hcl | 70 | $788 |
| Tramadol Hcl ErTramadol Hcl | 13 | $494 |
| Cyclobenzaprine Hcl | 34 | $362 |
| Celecoxib | 41 | $318 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $548 | $13,97421 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 162 physical medicine & rehabilitation providers in Arizona.
Other physical medicine & rehabilitation in Phoenix
- Azmi NasserPhoenix$46K
- Christina KwasnicaPhoenix$33K
- Keikhosrow MosallaiePhoenix$11K
- Heather TheobaldPhoenix$9K
- Grace MaloneyPhoenix$5K
- Vivek MehtaPhoenix$4K
- Brad SoroskyPhoenix$4K
- Tima lePhoenix$3K
- Julie HastingsPhoenix$3K
- Kevin LadinPhoenix$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.